ADMA Biologics Inc vs Oklo Inc — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Oklo Inc trades at $46.68 (market cap $8.74B). The key difference: Oklo Inc is far larger — about 3.9× ADMA Biologics Inc's market cap, and ADMA Biologics Inc is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | OKLO | |
|---|---|---|
Market Cap | $2.22B | $8.74B |
Sector | Health | Technology |
52-Week High | $20.38 | $174.14 |
52-Week Low | $7.60 | $36.84 |
Enterprise Value | $2.29B | $6.28B |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →